These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38798037)

  • 1. Increased CSF DOPA Decarboxylase Correlates with Lower DaT-SPECT Binding: Analyses in Biopark and PPMI Cohorts.
    Khosousi S; Sturchio A; Appleton E; Paslawski W; Ta M; Nalls M; Singleton AB; Iwaki H; Svenningsson P
    Mov Disord; 2024 May; ():. PubMed ID: 38798037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease.
    Muñoz-Delgado L; Labrador-Espinosa MÁ; Macías-García D; Jesús S; Benítez Zamora B; Fernández-Rodríguez P; Adarmes-Gómez AD; Reina Castillo MI; Castro-Labrador S; Silva-Rodríguez J; Carrillo F; García Solís D; Grothe MJ; Mir P
    Mov Disord; 2023 May; 38(5):755-763. PubMed ID: 36912400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis.
    Lee JY; Lao-Kaim NP; Pasquini J; Deuschl G; Pavese N; Piccini P
    Parkinsonism Relat Disord; 2018 Jun; 51():101-104. PubMed ID: 29503156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
    Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
    Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes.
    Goto R; Kurihara M; Kameyama M; Komatsu H; Higashino M; Hatano K; Ihara R; Higashihara M; Nishina Y; Matsubara T; Kanemaru K; Saito Y; Murayama S; Iwata A
    J Neural Transm (Vienna); 2023 Apr; 130(4):513-520. PubMed ID: 36871130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease.
    Rutledge J; Lehallier B; Zarifkar P; Losada PM; Shahid-Besanti M; Western D; Gorijala P; Ryman S; Yutsis M; Deutsch GK; Mormino E; Trelle A; Wagner AD; Kerchner GA; Tian L; Cruchaga C; Henderson VW; Montine TJ; Borghammer P; Wyss-Coray T; Poston KL
    Acta Neuropathol; 2024 Mar; 147(1):52. PubMed ID: 38467937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease.
    Paslawski W; Khosousi S; Hertz E; Markaki I; Boxer A; Svenningsson P
    Transl Neurodegener; 2023 Sep; 12(1):42. PubMed ID: 37667404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms.
    Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
    Nucl Med Commun; 2005 May; 26(5):421-6. PubMed ID: 15838424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Extrastriatal
    Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
    J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined use of dopamine transporter imaging (DAT-SPECT) and
    Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
    J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI study.
    Koros C; Simitsi AM; Prentakis A; Papagiannakis N; Bougea A; Pachi I; Papadimitriou D; Beratis I; Papageorgiou SG; Stamelou M; Trapali XG; Stefanis L
    Parkinsonism Relat Disord; 2020 Aug; 77():36-42. PubMed ID: 32615498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine Transporter Availability in Early Parkinson's Disease is Dependent on Sunlight Exposure.
    Booij J; Tellier SP; Seibyl J; Vriend C
    Mov Disord; 2023 Nov; 38(11):2131-2135. PubMed ID: 37670567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.
    Marek K; Chowdhury S; Siderowf A; Lasch S; Coffey CS; Caspell-Garcia C; Simuni T; Jennings D; Tanner CM; Trojanowski JQ; Shaw LM; Seibyl J; Schuff N; Singleton A; Kieburtz K; Toga AW; Mollenhauer B; Galasko D; Chahine LM; Weintraub D; Foroud T; Tosun-Turgut D; Poston K; Arnedo V; Frasier M; Sherer T;
    Ann Clin Transl Neurol; 2018 Dec; 5(12):1460-1477. PubMed ID: 30564614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
    Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
    Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT.
    Varrone A; Sansone V; Pellecchia MT; Amboni M; Salvatore E; De Michele G; Filla A; Barone P; Pappatà S; Salvatore M
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1343-9. PubMed ID: 18283454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models.
    Ito Y; Fujita M; Shimada S; Watanabe Y; Okada T; Kusuoka H; Tohyama M; Nishimura T
    Synapse; 1999 Mar; 31(3):178-85. PubMed ID: 10029235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments.
    Rahmim A; Salimpour Y; Jain S; Blinder SA; Klyuzhin IS; Smith GS; Mari Z; Sossi V
    Neuroimage Clin; 2016; 12():e1-e9. PubMed ID: 27995072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.